PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
23.16%
Some net income increase while AVGO is negative at -16.62%. John Neff would see a short-term edge over the struggling competitor.
7.80%
D&A growth well above AVGO's 1.66%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-621.80%
Negative yoy working capital usage while AVGO is 0.84%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-373.22%
Both reduce yoy inventory, with AVGO at -49.54%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
No Data
No Data available this quarter, please select a different quarter.
7.76%
Some yoy usage while AVGO is negative at -55.52%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
348.99%
Some yoy increase while AVGO is negative at -16.42%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
126.49%
Operating cash flow growth above 1.5x AVGO's 9.32%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-2.12%
Negative yoy CapEx while AVGO is 1.39%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.12%
We reduce yoy invests while AVGO stands at 170.68%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-38.59%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.